Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-066881

Chief Development Officer sold 30,000 shares at $32.00 ($960,000)

  • Chief Development Officer acquired 30,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Guyer William · Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-28 Exercise or conversion : show line 1 in the form 10b5-1 +30,000 $19.26 $577,800 36,039 D
2024-05-28 Sale : show line 2 in the form 10b5-1 −30,000 $32.00 $960,000 6,039 D
Open-market sales · 30,000 sh · avg $32.00 · $960,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-28 Exercise or conversion : show line 3 in the form 10b5-1 Stock option (right to buy) −30,000 60,000 D
Loading xslF345X05/ownership.xml…